Collagen VI-Related Myopathy Overview
Learn About Collagen VI-Related Myopathy
Collagen VI-related dystrophy is a group of disorders that affect skeletal muscles (which are the muscles used for movement) and connective tissue (which provides strength and flexibility to the skin, joints, and other structures throughout the body). Most affected individuals have muscle weakness and joint deformities called contractures that restrict movement of the affected joints and worsen over time. Researchers have described several forms of collagen VI-related dystrophy, which range in severity: Bethlem muscular dystrophy is the mildest, an intermediate form is moderate in severity, and Ullrich congenital muscular dystrophy is the most severe.
Variants (also known as mutations) in the COL6A1, COL6A2, and COL6A3 genes can cause the various forms of collagen VI-related dystrophy. These genes each provide instructions for making one component of a protein called type VI collagen. Type VI collagen makes up part of the extracellular matrix that surrounds muscle cells and connective tissue. This matrix is an intricate lattice that forms in the space between cells and provides structural support. The extracellular matrix is necessary for cell stability and growth. Research suggests that type VI collagen helps secure and organize the extracellular matrix by linking the matrix to the cells it surrounds.
Collagen VI-related dystrophy is rare. Bethlem muscular dystrophy is estimated to occur in 0.77 per 100,000 individuals, and Ullrich congenital muscular dystrophy is estimated to occur in 0.13 per 100,000 individuals. Only a few cases of the intermediate form have been described in the scientific literature.
Collagen VI-related dystrophy is often inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Bethlem muscular dystrophy is typically inherited in an autosomal dominant manner. The affected person usually inherits the variant from one affected parent. The intermediate form and Ullrich congenital muscular dystrophy can also follow an autosomal dominant inheritance pattern. These forms typically result from new variants in the gene and occur in people with no history of the disorder in their family.
Dell Childrens Medical Group
Vettaikorumakankav Vedanarayanan is a Pediatric Neurologist and a Pediatrics provider in Austin, Texas. Dr. Vedanarayanan and is rated as an Advanced provider by MediFind in the treatment of Collagen VI-Related Myopathy. His top areas of expertise are Inclusion Body Myositis, Congenital Myasthenic Syndrome, Amyotonia Congenita, and Limb-Girdle Muscular Dystrophy Type 1B. Dr. Vedanarayanan is currently accepting new patients.
University Of Texas Health Science Center At San Antonio
Matthew Wicklund is a Neurologist in San Antonio, Texas. Dr. Wicklund and is rated as an Advanced provider by MediFind in the treatment of Collagen VI-Related Myopathy. His top areas of expertise are Limb-Girdle Muscular Dystrophy, Inclusion Body Myositis, Limb-Girdle Muscular Dystrophy Type 2I, and Paramyotonia Congenita. Dr. Wicklund is currently accepting new patients.
Dewitt Medical District
David Hill is a Family Medicine provider in Cuero, Texas. Dr. Hill and is rated as an Experienced provider by MediFind in the treatment of Collagen VI-Related Myopathy. His top areas of expertise are Opioid Use Disorder, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension.
Summary: Muscular Myopathies are a heterogenous group of inherited muscular disorders characterized by progressive muscle weakness. Historically, these disorders are difficult to treat. In the last three decades, there is a great progress in molecular and genetic basis of these disorders; early diagnosis is achievable with proper clinical recognition and advanced genetic testing \[1\]. Duchenne Muscular Dy...
Summary: The Global Registry for COL6-related dystrophies (www.collagen6.org) is a database for individuals who have been diagnosed with Bethlem Myopathy, Ullrich Congenital Muscular Dystrophy (UCMD) or an intermediate form of these diseases. The registry team is based at the John Walton Muscular Dystrophy Research Centre at Newcastle University, UK and is part of the TREAT-NMD alliance global network of r...
Published Date: July 19, 2022
Published By: National Institutes of Health